Company page
Sab Biotherapeutics, Inc.
Sab Biotherapeutics, Inc. (ticker: SABS) is a public company based in the United States, specializing in biotherapeutics. With a market capitalization of approximately $305.9 million, the company focuses on developing innovative treatments to address various health conditions.
- Ticker
- SABS:NASDAQ
- Asset type
- Stock
- Market cap
- $305.9M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD